Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours.
about
Peptide-based probes for targeted molecular imaging.Peptides and peptide hormones for molecular imaging and disease diagnosisComparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607.Influence of d-glutamine and d-glutamic acid sequences in optical peptide probes targeted against the cholecystokinin-2/gastrin-receptor on binding affinity, specificity and pharmacokinetic properties.Inorganic chemistry in nuclear imaging and radiotherapy: current and future directions.Preclinical evaluation of 68Ga-DOTA-minigastrin for the detection of cholecystokinin-2/gastrin receptor-positive tumors.Comparative biodistribution of 12 ¹¹¹In-labelled gastrin/CCK2 receptor-targeting peptidesInfluence of a novel, versatile bifunctional chelator on theranostic properties of a minigastrin analogue.From preclinical development to clinical application: Kit formulation for radiolabelling the minigastrin analogue CP04 with In-111 for a first-in-human clinical trial.Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with (111)In-CP04 in medullary thyroid carcinoma patientsComparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma.Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumorsCurrent Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms.Radiometallated peptides for molecular imaging and targeted therapy.Radiopharmaceutical development of radiolabelled peptides.Radiolabelled peptides for oncological diagnosis.Methoxinine - an alternative stable amino acid substitute for oxidation-sensitive methionine in radiolabelled peptide conjugates.Molecular imaging probes derived from natural peptides.Affinity maturation of an ERBB2-targeted SPECT imaging peptide by in vivo phage display.Preclinical evaluation of radiolabeled DOTA-derivatized cyclic minigastrin analogs for targeting cholecystokinin receptor expressing malignancies.Comparison of the binding and internalization properties of 12 DOTA-coupled and ¹¹¹In-labelled CCK2/gastrin receptor binding peptides: a collaborative project under COST Action BM0607.Gastrin and cholecystokinin peptide-based radiopharmaceuticals: an in vivo and in vitro comparison.1,2,3-Triazoles as amide bond mimics: triazole scan yields protease-resistant peptidomimetics for tumor targeting.Structural studies on radiopharmaceutical DOTA-minigastrin analogue (CP04) complexes and their interaction with CCK2 receptor.Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting.
P2860
Q33526620-F89BEEC6-33FA-4CA4-8ABB-D4FCF8D18FE4Q33846924-27E44BD4-6ADB-4545-B43D-E6DB8339148BQ33884461-5CCE4AE9-69BA-43D7-BE05-0E329D3B6848Q34250142-8CC6EADC-45AC-45C4-A56E-CA5D38D5430DQ34460892-25C0CF83-DEB2-4B4A-9D18-5F7106F204FEQ35069148-4BDE5039-ABDB-4744-8536-7FFA27C148FDQ35078943-986C6E6C-F448-4165-9D1D-B99DD9493B92Q36373488-D255DD22-2D12-47FD-A6DC-C7DA417D44C4Q36755148-886F2EE5-D3FA-4B23-85AA-95826D5049DFQ37103342-08CBACCD-91C6-4F27-AC26-3004EFDE7AD8Q37258209-CFA6735B-5476-4548-94CE-054921A0AD3BQ37701765-1EA93F00-D83F-40E4-B64E-C387A510764AQ37731335-E1E64ABA-B100-48B9-88AB-7B7A87CCF0D2Q37847064-E02077B1-CBC3-4333-9493-6F7785833067Q37990399-ACB16644-B92C-4B4D-ABCC-09F7CDDADAD5Q37990405-40CBB0FC-3D8C-453E-9364-932603315D8CQ38722877-5455F2F3-4DEF-4A62-AC8D-3EE047BB6AF7Q38748846-5984E077-75BE-4A4F-97AC-00B3025210AEQ39022761-448D728F-7B32-4F56-A865-619B410FE52BQ39512185-2071FE07-38B1-4309-A3BE-B95BED4F3F2DQ39552291-507F6854-805B-4ED2-8CC6-E4E26B730BD7Q39586152-F02A306F-FCA5-4F82-88E4-C135C4D0E12AQ44277672-54E14434-80EE-4B35-8D94-79A194BCAAACQ52319422-BA57BF52-5B85-44AE-A247-139C88847C4BQ55098217-020F41E8-30A0-44B2-B919-DC537535954C
P2860
Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Macrocyclic chelator-coupled g ...... n receptor-expressing tumours.
@en
Macrocyclic chelator-coupled g ...... n receptor-expressing tumours.
@nl
type
label
Macrocyclic chelator-coupled g ...... n receptor-expressing tumours.
@en
Macrocyclic chelator-coupled g ...... n receptor-expressing tumours.
@nl
prefLabel
Macrocyclic chelator-coupled g ...... n receptor-expressing tumours.
@en
Macrocyclic chelator-coupled g ...... n receptor-expressing tumours.
@nl
P2093
P1476
Macrocyclic chelator-coupled g ...... in receptor-expressing tumours
@en
P2093
Beatrice Waser
Helmut R Maecke
Jan Müller-Brand
Jean-Claude Reubi
Martin P Béhé
Stephan Good
Xuejuan Wang
P2888
P304
P356
10.1007/S00259-008-0803-4
P577
2008-05-29T00:00:00Z